New Lung Cancer Medication – Revealing Afatinib’s Meaning Most lung cancer cases are classified as the non-small-cell type. For years, patients suffering from the disease’s rarer form (where genes that function as growth factor receptors have mutated) had to rely on medication that is not specifically made for their condition. Finally, the FDA approved the […]
Louis Kraml’s Medical News Review – September 2013
1. Inconsistency of Anti-Hypertensive Medication Increases Risk of Stroke Research featured in the European Heart Journal has unveiled that the ill practices of hypertensive patients can be detrimental. The study aims to emphasize that the correct doses of treatment is important as it could prevent mild to severe cases of stroke which ultimately lead to […]
Louis Kraml’s Medical News Review – March 2013
1. When people have a positive perspective on aging, recovery is much better, says a new research that has been conducted in the U.S. On the other hand, people that have a negative perspective get well much harder and over a longer period of time. The question that arises is if positive thinking has indeed […]
Chapel Hill Tubal Reversal Center Surgeons Make Medical News
Dr. Charles Monteith and Dr. Gary Berger of Chapel Hill Tubal Reversal Center have authored "Successful pregnancies after removal of intratubal microinserts" published in the February 2012 edition of Obstetrics and Gynecology pages 470-472. This article is the first of its kind concerning the successful reversal of intratubal microinserts. Having experienced very successful reversal of […]
NYSE:FMS Shareholder News: Investigation over possible Securities Laws Violations by Fresenius Medical Care AG & Co.
An investigation for investors in NYSE:FMS shares was announced concerning possible violations of securities laws by Fresenius Medical Care AG & Co. and certain of its directors and officers. Investors who purchased shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call […]
Investor News: Deadline upcoming in the Settlement of the Lawsuit against St Jude Medical Inc (NYSE: STJ)
A deadline is coming up on December 8, 2016 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased NYSE: STJ shares between February 5, 2010 and November 20, 2012. Investors who purchased a significant amount of shares of St Jude Medical Inc (NYSE: STJ) between February 5, […]
- 1
- 2
- 3
- …
- 315
- Next Page »